Interview with Ken Duncan on COVID-19 (novel coronavirus). Duncan leads drug discovery efforts for the Bill & Melinda Gates Foundation's Discovery & Translational Sciences team.
We are joining forces with Wellcome and Mastercard to beef up our COVID-19 response—backed by $125 million in both new funding and money already earmarked to tackle this epidemic. The expertise of pharmaceutical companies will be critical to this endeavor, named the COVID-19 Therapeutics Accelerator
Sign up for The Optimist newsletter
Subscribe to The Optimist to get updates on the latest in global health, gender equality, education, and more. Subscribing and completing your profile is the best way to stay up to date with the Gates Foundation, our partners, events, and other ways to stay connected.